<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>844</ReferenceId>
        <DateLastUpdated>2018-10-16-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11714749</PubmedId>
            <Abstract>Mycobacterium tuberculosis (MTB) inhibits phagosomal maturation to promote its survival inside macrophages. Control of MTB infection requires CD4 T cell responses and major histocompatibility complex (MHC) class II (MHC-II) processing of MTB antigens (Ags). To investigate phagosomal processing of MTB Ags, phagosomes containing heat-killed (HK) or live MTB were purified from interferon-gamma (IFN-gamma)-activated macrophages by differential centrifugation and Percoll density gradient subcellular fractionation. Flow organellometry and Western blot analysis showed that MTB phagosomes acquired lysosome-associated membrane protein-1 (LAMP-1), MHC-II, and H2-DM. T hybridoma cells were used to detect MTB Ag 85B(241-256)-I-A(b) complexes in isolated phagosomes and other subcellular fractions. These complexes appeared initially (within 20 min) in phagosomes and subsequently (&gt;20 min) on the plasma membrane, but never within late endocytic compartments. Macrophages processed HK MTB more rapidly and efficiently than live MTB; phagosomes containing live MTB expressed fewer Ag 85B(241-256)-I-A(b) complexes than phagosomes containing HK MTB. This is the first study of bacterial Ag processing to directly show that peptide-MHC-II complexes are formed within phagosomes and not after export of bacterial Ags from phagosomes to endocytic Ag processing compartments. Live MTB can alter phagosome maturation and decrease MHC-II Ag processing, providing a mechanism for MTB to evade immune surveillance and enhance its survival within the host.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>1421-32</ArticlePages>
            <ArticleTitle>Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Ramachandra</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Noss</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Boom</LastName>
                    <ForeName>W H</ForeName>
                </Author>
                <Author>
                    <LastName>Harding</LastName>
                    <ForeName>C V</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institute of Pathology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-4943 USA. lxr2@po.cwru.edu.</Affiliations>
            <ArticleChemicalList>Antigens, Bacterial;Antigens, CD;Antigens, Differentiation, B-Lymphocyte;Bacterial Proteins;H2-M antigens;Histocompatibility Antigens Class II;Lysosome-Associated Membrane Glycoproteins;Membrane Glycoproteins;invariant chain;Acyltransferases;antigen 85B, Mycobacterium tuberculosis</ArticleChemicalList>
            <ArticleMeshHeadingsList>Acyltransferases; Animals; Antigen Presentation; Antigens, Bacterial; Antigens, CD(metabolism); Antigens, Differentiation, B-Lymphocyte(analysis); Bacterial Proteins(metabolism); Blotting, Western; Centrifugation, Density Gradient; Histocompatibility Antigens Class II(analysis; metabolism); Lysosome-Associated Membrane Glycoproteins; Membrane Glycoproteins(metabolism); Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis(immunology); Phagosomes(metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>194</Volume>
                <Issue>10</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>85B (241-256)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VANNTRLWVYCGNGTP</LinearSequence>
                        <StartingPosition>241</StartingPosition>
                        <EndingPosition>256</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P31952</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>1773</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 1422,</LocationOfData>
                <EpitopeId>67696</EpitopeId>
                <ReferenceStartingPosition>241</ReferenceStartingPosition>
                <ReferenceEndingPosition>256</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>85B is conserved across mycobacterial species and belongs to the Ag 85 family of proteins that function in cell wall mycolic acid synthesis; Swiss-Prot entry names are Antigen 85-B precursor (85B), Extracellular alpha-antigen, Antigen 85 complex B, Ag85B, and Mycolyl transferase 85B.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Fig 6</LocationOfData>
                        <TCellId>9618</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P31952</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>85B</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Information on the origin of T cell line used as a probe for antigen presentation was extracted from a previous reference (PMID 11441098). Lymph node cells were fused to BW5147 cells to generate the T hybridoma cell line BB7 used for the assays.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>10000220</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Macrophages present epitope from heat-killed M. tuberculosis (MTB) more rapidly than from live MTB. Low MOI infection allows activation only by HK but not by live bacteria (Fig 7), implying the less efficient generation of MHC-II-epitope complex is a consequence of live bacterial activity (Fig 7). This is related to the inhibition of phagosomal maturation seen in live MTB-infected macrophages by means of reduced lysosomal LAMP-1content (Fig 3).  T cell response is monitored by IL-2 secretion by CTLL-2 proliferation assay.  Heat-killed (HK) mycobacterium primed macrophages are fixed in paraformaldehyde before addition of T cell line.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Fig 1</LocationOfData>
                        <TCellId>9115</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000067</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P31952</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>1773</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>85B</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>Information on the origin of T cell line used as a probe for antigen presentation was extracted from a previous reference (PMID 11441098). Lymph node cells were fused to BW5147 cells to generate the T hybridoma cell line BB7 used for the assays.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Macrophage</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <SourceOrganismId>10000220</SourceOrganismId>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>1773</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>62</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Macrophages present epitope from heat-killed M. tuberculosis to T cell line under normal conditions but not if processing is inhibited by cytochalasin D or chloroquine, or if macrophages form H2-DM -/- mice are used, implying activation results from bona fide Ag presentation.T cell response is monitored by IL-2 secretion by CTLL-2 proliferation assay.  Heat-killed (HK) mycobacterium primed macrophages are fixed in paraformaldehyde before addition of T cell line.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

